VirnetX Holding Corp Launches At-the-Market Offering

What Happened

• On October 1, 2026, VirnetX Holding Corporation (VHC) entered into an At the Market Offering Agreement with Titan Partners Securities LLC as agent to sell, from time to time, up to $19,135,717 of its common stock under its shelf registration (Form S-3, File No. 333-295960). The company filed a prospectus supplement dated October 1, 2026. Net proceeds, if any, are intended for product development, marketing and general corporate purposes (including working capital and capital expenditures). The agent will use commercially reasonable efforts to sell shares but the company is not obligated to sell any shares.

Key Details

• Aggregate amount available to sell: $19,135,717 of common stock.
• Sales agent: Titan Partners Securities LLC; commission: 3.0% of gross sales price.
• Shares sold pursuant to the company’s Form S-3 shelf registration (File No. 333-295960); prospectus supplement filed 10/01/2026.
• Sales may occur on Nasdaq or other trading markets, through market makers, or in privately negotiated transactions with prior written consent.

Why It Matters

• This ATM program gives VirnetX flexible access to capital but does not guarantee any proceeds—actual fundraising depends on if/when shares are sold and market conditions.
• Future sales would dilute existing shareholders and could affect metrics like earnings per share; investors should watch future 8-Ks or 10-Q/10-K disclosures for actual sales amounts, timing, and use of proceeds.
• The 3% sales commission and market timing will affect net proceeds; legal opinion from Wilson Sonsini is filed with the 8-K.